Evidence map›Paper›PMID 39714067›Full record

ArticleNano letters2025

Protein-Enabled Size-Selective Defect-Sealing of Atomically Thin 2D Membranes for Dialysis and Nanoscale Separations.

Peifu Cheng, Nicholas Ferrell, Saban M Hus, Nicole K Moehring, Matthew J Coupin, Jamie Warner, An-Ping Li, William H Fissell, Piran R Kidambi

Abstract read
In one paragraph

Article in Nano letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Peifu ChengDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee 37212, United States.
Nicholas FerrellDivision of Nephrology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210, United States.
Saban M HusCenter for Nanophase Materials Sciences, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, United States.
Nicole K MoehringInterdisciplinary Materials Science Program, Vanderbilt University, Nashville, Tennessee 37212, United States.
Matthew J CoupinWalker Department of Mechanical Engineering, University of Texas at Austin, Austin, Texas 78712-1591, United States.ORCID 0000-0001-6020-1013
Jamie WarnerWalker Department of Mechanical Engineering, University of Texas at Austin, Austin, Texas 78712-1591, United States.ORCID 0000-0002-1271-2019
An-Ping LiCenter for Nanophase Materials Sciences, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, United States.ORCID 0000-0003-4400-7493
William H FissellDepartment of Medicine and Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States.
Piran R KidambiDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee 37212, United States.ORCID 0000-0003-1546-5014

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atomically thin 2D materials present the potential for advancing membrane separations via a combination of high selectivity (from molecular sieving) and high permeance (due to atomic thinness). However, the creation of a high density of precise nanopores (narrow-size-distribution) over large areas in 2D materials remains challenging, and nonselective leakage from nanopore heterogeneity adversely impacts performance. Here, we demonstrate protein-enabled size-selective defect sealing (PDS) for atomically thin graphene membranes over centimeter scale areas by leveraging the size and reactivity of permeating proteins to preferentially seal larger nanopores (≥4 nm) while preserving a significant amount of smaller nanopores (via steric hindrance). Our defect-sealed nanoporous atomically thin membranes (NATMs) show stability up to ∼35 days during size-selective diffusive separations with a model dialysis biomolecule fluorescein isothiocyanate (FITC)-Ficoll 70 in phosphate buffer saline (PBS) solution as well as outperform state-of-the-art commercially available dialysis membranes (molecular-weight-cutoff ∼3.5-5 kDa and ∼8-10 kDa) with significantly higher permeance for smaller solutes KCl (∼0.66 nm) ∼5.1-6 × 10

Indexed as

GraphiteMembranes, ArtificialNanoporesDialysisFluorescein-5-isothiocyanateMuramidaseParticle SizeProteinsFluorescein-5-isothiocyanateGraphiteMembranes, ArtificialMuramidaseProteinsatomically thin membranesgraphenehighly selective membranesnanoscale separationsprotein-enabled defect sealing

Identifiers

PMID39714067
PMCPMC11719630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.